查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2081932

避孕藥市場：2026-2032年全球市場預測（依產品類型、作用機制、材料類型、保存期限、使用頻率、銷售管道、應用及最終用戶分類）

Contraceptive Market by Product Type, Mode Of Action, Material Type, Duration, Usage Frequency, Sales Channel, Application, End-User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，避孕藥具市場規模將成長至 690.2 億美元，複合年成長率為 7.67%。

主要市場統計數據
基準年 2025 411.3億美元
預計年份：2026年 441.3億美元
預測年份 2032 690.2億美元
複合年成長率 (%) 7.67%

避孕市場執行摘要

避孕市場在女性健康、生殖醫學、消費者保健和公共衛生政策領域都扮演著極為重要的角色。其需求受到全球可衡量的需求所驅動。根據世界衛生組織（世衛組織）統計，約有11億育齡婦女需要計劃生育服務，其中約8.74億人使用現代避孕方法，而約有1.64億人的需求尚未得到滿足。

避孕市場發生變革性變化

避孕產業正從以產品為中心的模式轉向更廣泛的生殖健康生態系統。消費者和醫療保健系統越來越重視避孕選擇、副作用管理、無需每日使用的方案、非處方購買、私密獲取以及全面諮詢服務。長效可逆避孕法因其高效性仍十分重要，而保險套在預防懷孕和減少性行為感染感染方面繼續發揮雙重作用。

人工智慧（AI）的累積影響

人工智慧 (AI) 正透過需求預測、庫存最佳化、病患教育、臨床決策支援和藥物安全監測等方式，開始影響避孕領域。人工智慧驅動的分析可以幫助公共專案減少缺貨情況，識別服務缺陷，並最佳化針對特定人群（存在未滿足需求）的支援活動。

關鍵區域洞察

亞太地區因其龐大的人口規模、都市化和龐大的育齡人口，在全球避孕需求中佔據中心地位。中國和印度憑藉其完善的公共衛生體系和國內生產能力，為該地區的需求提供了有力支撐。同時，日本、韓國、澳洲和東協等市場的避孕藥具使用模式各不相同，這主要受出生率趨勢、臨床指南、替代療法的可及性以及對長效可逆避孕方法的認知等因素的影響。北美地區仍然是一個高價值市場，這得益於其完善的醫保報銷機制、產品創新、遠端醫療基礎設施和成熟的臨床路徑，但不同州、省、保險公司和收入水平人群的避孕藥具獲取情況存在差異。

對關鍵群體的洞察

在東協地區，公共計畫、私人藥房、社區醫療服務以及日益普及的數位醫療等多種手段共同促進了避孕措施的普及。印尼、菲律賓、越南、泰國和馬來西亞的政策、宗教和文化環境各不相同。在海灣合作理事會（GCC）國家，高昂的醫療費用支出和保守的社會規範催生了對謹慎、醫生指導且符合文化習俗的生殖健康服務的需求，這些服務優先考慮隱私和醫患信任。

主要國家的概況

在美國，保險覆蓋範圍、生殖健康政策、遠端醫療、藥劑師服務以及非處方避孕藥的可近性影響避孕現狀。在加拿大，透過省級和聯邦政府擴大保險覆蓋範圍的努力，避孕藥的可及性正在改善。墨西哥和巴西依靠一套結合公共計畫和私人藥房服務的體系，這得益於龐大的育齡人口以及青少年和農村地區對避孕藥的持續需求。在歐洲，英國、德國、法國、義大利和西班牙是成熟的市場，保險報銷、處方規範、基層醫療服務以及諮詢品質都會影響避孕藥的選擇。而俄羅斯則有著獨特的人口結構特點，且私部門對避孕藥的需求龐大。

為行業領導者提供的實用建議

產業領導者應優先考慮以實證醫學為基礎的產品系列，包括短效、長效、非荷爾蒙避孕方法、緊急避孕藥和屏障避孕法。最有效的策略是將臨床療效與消費者體驗結合，後者包括副作用資訊的透明度、價格合理、隱密的配送、文化敏感的諮詢服務以及後續支援。

調查方法

本執行摘要是基於對來自世界衛生組織 (WHO)、聯合國機構、Gutmacker 研究所、國家衛生當局和同行評審的生殖健康文獻等來源的檢驗的公共衛生和行業證據的結構化審查。

結論

避孕是一項至關重要的健康領域，它能為孕產婦健康、教育、勞動參與和經濟韌性帶來顯著益處。該行業的下一階段將以更廣泛的普及、更豐富的避孕選擇、更安全的諮詢、數位技術的應用、負責任的人工智慧技術的應用以及可靠的供應為特徵。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 避孕藥具市場：依產品類型分類

  • 避孕藥
    • 口服避孕藥
    • 事後緊急避孕藥
    • 注射式避孕藥
  • 避孕藥
    • 避孕器（IUD）
      • 釋放荷爾蒙的子宮內避孕器
      • 銅子宮內避孕器
    • 植入式避孕器
    • 陰道環
    • 避孕貼片
  • 障礙法
    • 男用保險套
    • 女性用保險套
    • 隔膜
    • 子宮頸帽
  • 永久避孕
    • 輸卵管結紮
    • 血管結紮術

第8章：避孕藥市場：依作用機轉分類

  • 植入預防
  • 殺精作用
  • 抑制排卵

第9章：避孕藥市場：依材料類型分類

  • 基於乳膠
  • 非乳膠
    • 丁腈橡膠
    • 聚異戊二烯
    • 聚氨酯

第10章：避孕藥市場：依時期分類

  • 長期
  • 短期

第11章：避孕藥具市場：依使用頻率分類

  • 一經請求
  • 經常使用

第12章 避孕藥市場：依銷售管道分類

  • 離線
    • 醫院藥房
    • 藥局
  • 線上
    • 電子商務平台
    • 網路藥房

第13章 避孕藥市場：依應用領域分類

  • 一般
  • 性交後使用

第14章 避孕藥市場：依最終用戶分類

  • 女士
    • 青春期
    • 成人
    • 停經後
  • 男性

第15章 避孕藥市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第16章 避孕藥市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章 避孕藥市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第19章：公司簡介

  • AbbVie Inc.
  • Afaxys, Inc.
  • Agile Therapeutics, Inc.
  • Allergan plc
  • Bayer AG
  • Church & Dwight Co., Inc.
  • Cipla Limited
  • CooperSurgical, Inc.
  • DKT International
  • Dr. Reddy's Laboratories Ltd.
  • Famy Care Ltd.
  • GlaxoSmithKline plc
  • Glenmark Pharmaceuticals Ltd.
  • HLL Lifecare Limited
  • Johnson & Johnson
  • Karex Berhad
  • Lupin Limited
  • Merck & Co., Inc.
  • Mylan NV
  • Novartis AG
  • Organon & Co.
  • Pfizer Inc.
  • Piramal Pharma Limited
  • Pregna International Limited
  • Reckitt Benckiser Group plc
  • Shanghai Dahua Pharmaceutical Co., Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • The Cooper Companies, Inc.
  • Viatris Inc.
Product Code: MRR-4316E4E895C4

The Contraceptive Market is projected to grow by USD 69.02 billion at a CAGR of 7.67% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 41.13 billion
Estimated Year [2026] USD 44.13 billion
Forecast Year [2032] USD 69.02 billion
CAGR (%) 7.67%

Contraceptive Executive Summary

The contraceptive landscape is a high-impact segment of women's health, reproductive medicine, consumer health, and public health policy. Demand is supported by measurable global need: the World Health Organization reports that roughly 1.1 billion women of reproductive age need family planning, including about 874 million using modern contraceptive methods and about 164 million with an unmet need.

For industry leaders, contraception is no longer limited to oral contraceptive pills. The category spans condoms, intrauterine devices, implants, injectables, emergency contraception, vaginal rings, patches, fertility-awareness tools, and digital contraceptive platforms. Opportunities are strongest where access, affordability, counseling quality, product choice, privacy, and supply-chain reliability align with evidence-based reproductive health needs.

Transformative Shifts in the Contraceptive Landscape

The contraceptive landscape is shifting from a product-centric model to a broader reproductive health ecosystem. Consumers and health systems increasingly prioritize method choice, side-effect management, non-daily options, over-the-counter availability, discreet access, and integrated counseling. Long-acting reversible contraceptives remain important because of high effectiveness, while condoms continue to play a dual role in pregnancy prevention and sexually transmitted infection reduction.

Policy is also reshaping the category. Expanded insurance coverage, public procurement, telehealth prescribing, pharmacist-led access, and self-care models are improving reach in many countries. At the same time, regulatory scrutiny, misinformation, cultural barriers, and inconsistent funding continue to influence adoption, continuation, and equitable access to contraceptive care.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is beginning to influence contraception through demand forecasting, inventory optimization, patient education, clinical decision support, and pharmacovigilance. AI-enabled analytics can help public programs reduce stockouts, identify service gaps, and tailor outreach to populations with documented unmet need.

The highest-value applications are likely to be responsible AI tools that support counseling without replacing clinicians. Algorithms can help personalize method discussions around medical eligibility, adherence preferences, side-effect concerns, and follow-up needs. However, deployment must address bias, privacy, reproductive autonomy, cybersecurity, and transparency, especially because contraceptive decisions involve sensitive health and personal data.

Key Regional Insights

Asia-Pacific is central to global contraceptive demand because of its population scale, urbanization, and large reproductive-age cohort. China and India anchor regional volume through extensive public health systems and domestic production capacity, while Japan, South Korea, Australia, and ASEAN markets show distinct adoption patterns shaped by fertility trends, clinical guidelines, private care access, and awareness of long-acting reversible contraception. North America remains a high-value region supported by reimbursement mechanisms, product innovation, telehealth infrastructure, and established clinical pathways, although access varies by state, province, payer, and income level.

Latin America has broad public-sector family planning programs and strong demand for injectables, implants, condoms, and oral contraceptives, but access gaps persist in rural, adolescent, Indigenous, and low-income communities. Europe is characterized by mature contraceptive use, national health systems, and strong regulatory oversight, with increasing attention to hormone-related concerns, method choice, affordability, and counseling standards. In the Middle East, contraceptive uptake is influenced by physician-led care, privacy expectations, and culturally aligned reproductive health services, while Africa remains closely linked to public health investment, donor procurement, supply-chain resilience, youth-friendly services, and community-based counseling to address documented unmet need.

Key Group Insights

Within ASEAN, contraceptive access is shaped by a mix of public programs, private pharmacies, community health services, and rising digital health use, with Indonesia, the Philippines, Vietnam, Thailand, and Malaysia representing diverse policy, religious, and cultural environments. The GCC combines high health spending with conservative social norms, creating demand for discreet, physician-guided, and culturally aligned reproductive health services that emphasize privacy and clinical trust.

The European Union offers a mature regulatory and reimbursement environment where safety monitoring, pharmacovigilance, adolescent access, and equitable affordability are central policy themes. BRICS countries are strategically important because Brazil, Russia, India, China, and South Africa combine large reproductive-age populations with different public procurement models, domestic manufacturing capabilities, and regional access gaps. G7 markets influence innovation, clinical standards, regulatory expectations, and premium product adoption, while NATO countries overlap substantially with advanced health systems where supply security, essential medicine availability, and resilient procurement are increasingly policy priorities.

Key Country Insights

The United States is shaped by insurance coverage, reproductive health policy, telehealth, pharmacist access, and over-the-counter contraception pathways, while Canada is expanding affordability through provincial and federal coverage initiatives. Mexico and Brazil rely on a mix of public-sector programs and private pharmacy access, with demand supported by large reproductive-age populations and ongoing needs for adolescent and rural access. In Europe, the United Kingdom, Germany, France, Italy, and Spain are mature markets where reimbursement, prescribing norms, primary-care access, and counseling quality affect method mix, while Russia has distinctive demographic priorities and meaningful private-sector demand.

In Asia-Pacific, China and India are scale markets where public health priorities, domestic production, urban-rural disparities, and regional access gaps shape contraceptive adoption. Japan has historically lower uptake of some hormonal methods compared with Western markets and continues to be influenced by physician prescribing practices and consumer attitudes toward hormones. Australia has strong primary-care access, reimbursement support, and high awareness of long-acting options. South Korea reflects advanced digital health adoption, urban access, and shifting fertility behavior, making it relevant for integrated reproductive health innovation.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize evidence-based product portfolios that include short-acting, long-acting, non-hormonal, emergency, and barrier methods. The strongest strategies will pair clinical effectiveness with consumer experience, including side-effect transparency, affordability, discreet distribution, culturally competent counseling, and follow-up support.

Organizations should invest in supply-chain resilience, responsible digital tools, pharmacovigilance, provider education, and partnerships with public health agencies. In lower-access markets, success depends on training providers, reducing stockouts, supporting youth-friendly services, expanding last-mile distribution, and aligning with WHO medical eligibility guidance and national family planning priorities.

Research Methodology

The executive summary is based on a structured review of verified public health and industry evidence from organizations such as the World Health Organization, United Nations agencies, the Guttmacher Institute, national health authorities, and peer-reviewed reproductive health literature.

The analysis emphasizes contraceptive prevalence, unmet need, method mix, policy access, reimbursement, regional health-system structure, supply-chain reliability, and technology adoption. Claims are limited to established trends and data-backed insights, avoiding unsupported market-size, market-share, or forecasting assumptions.

Conclusion

Contraception is an essential health category with measurable benefits for maternal health, education, workforce participation, and economic resilience. The industry's next phase will be defined by broader access, expanded method choice, safer counseling, digital enablement, responsible AI adoption, and reliable supply.

Leaders that combine scientific credibility, consumer trust, equitable pricing, privacy protection, and strong distribution will be best positioned. The most durable opportunities will come from serving both mature markets seeking convenience and emerging markets still working to close documented unmet need.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Contraceptive Market, by Product Type

  • 7.1. Contraceptive Drugs
    • 7.1.1. Oral Contraceptive Pills
    • 7.1.2. Emergency Contraceptive Pills
    • 7.1.3. Injectable Contraceptives
  • 7.2. Contraceptive Devices
    • 7.2.1. Intrauterine Devices (IUDs)
      • 7.2.1.1. Hormonal IUDs
      • 7.2.1.2. Copper IUDs
    • 7.2.2. Subdermal Implants
    • 7.2.3. Vaginal Rings
    • 7.2.4. Contraceptive Patches
  • 7.3. Barrier Methods
    • 7.3.1. Male Condoms
    • 7.3.2. Female Condoms
    • 7.3.3. Diaphragms
    • 7.3.4. Cervical Caps
  • 7.4. Permanent Methods
    • 7.4.1. Tubal Ligation
    • 7.4.2. Vasectomy

8. Contraceptive Market, by Mode Of Action

  • 8.1. Prevent Implantation
  • 8.2. Spermicidal Action
  • 8.3. Suppress Ovulation

9. Contraceptive Market, by Material Type

  • 9.1. Latex-Based
  • 9.2. Non-Latex
    • 9.2.1. Nitrile
    • 9.2.2. Polyisoprene
    • 9.2.3. Polyurethane

10. Contraceptive Market, by Duration

  • 10.1. Long-Term
  • 10.2. Short-Term

11. Contraceptive Market, by Usage Frequency

  • 11.1. On-Demand
  • 11.2. Regular Use

12. Contraceptive Market, by Sales Channel

  • 12.1. Offline
    • 12.1.1. Hospital Pharmacy
    • 12.1.2. Pharmacy
  • 12.2. Online
    • 12.2.1. E-Commerce Platforms
    • 12.2.2. Online Pharmacy

13. Contraceptive Market, by Application

  • 13.1. General Use
  • 13.2. Post-Coital Use

14. Contraceptive Market, by End-User

  • 14.1. Female
    • 14.1.1. Adolescent
    • 14.1.2. Adult
    • 14.1.3. Post-Menopausal
  • 14.2. Male

15. Contraceptive Market, by Region

  • 15.1. Asia-Pacific
  • 15.2. North America
  • 15.3. Latin America
  • 15.4. Europe
  • 15.5. Middle East
  • 15.6. Africa

16. Contraceptive Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Contraceptive Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025

19. Company Profiles

  • 19.1. AbbVie Inc.
  • 19.2. Afaxys, Inc.
  • 19.3. Agile Therapeutics, Inc.
  • 19.4. Allergan plc
  • 19.5. Bayer AG
  • 19.6. Church & Dwight Co., Inc.
  • 19.7. Cipla Limited
  • 19.8. CooperSurgical, Inc.
  • 19.9. DKT International
  • 19.10. Dr. Reddy's Laboratories Ltd.
  • 19.11. Famy Care Ltd.
  • 19.12. GlaxoSmithKline plc
  • 19.13. Glenmark Pharmaceuticals Ltd.
  • 19.14. HLL Lifecare Limited
  • 19.15. Johnson & Johnson
  • 19.16. Karex Berhad
  • 19.17. Lupin Limited
  • 19.18. Merck & Co., Inc.
  • 19.19. Mylan N.V.
  • 19.20. Novartis AG
  • 19.21. Organon & Co.
  • 19.22. Pfizer Inc.
  • 19.23. Piramal Pharma Limited
  • 19.24. Pregna International Limited
  • 19.25. Reckitt Benckiser Group plc
  • 19.26. Shanghai Dahua Pharmaceutical Co., Ltd.
  • 19.27. Sun Pharmaceutical Industries Ltd.
  • 19.28. Teva Pharmaceutical Industries Ltd.
  • 19.29. The Cooper Companies, Inc.
  • 19.30. Viatris Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CONTRACEPTIVE MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL CONTRACEPTIVE MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL CONTRACEPTIVE MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL CONTRACEPTIVE MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL CONTRACEPTIVE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL CONTRACEPTIVE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DURATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DURATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL CONTRACEPTIVE MARKET SIZE, BY END-USER, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL CONTRACEPTIVE MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL CONTRACEPTIVE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL CONTRACEPTIVE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL CONTRACEPTIVE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 27. GLOBAL CONTRACEPTIVE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 29. GLOBAL CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CONTRACEPTIVE DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CONTRACEPTIVE DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CONTRACEPTIVE DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL INJECTABLE CONTRACEPTIVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL INJECTABLE CONTRACEPTIVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL INJECTABLE CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CONTRACEPTIVE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CONTRACEPTIVE DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CONTRACEPTIVE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL INTRAUTERINE DEVICES (IUDS) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTRAUTERINE DEVICES (IUDS) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL INTRAUTERINE DEVICES (IUDS) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HORMONAL IUDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HORMONAL IUDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HORMONAL IUDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL COPPER IUDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL COPPER IUDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL COPPER IUDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SUBDERMAL IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SUBDERMAL IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SUBDERMAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL VAGINAL RINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL VAGINAL RINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL VAGINAL RINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CONTRACEPTIVE PATCHES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CONTRACEPTIVE PATCHES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CONTRACEPTIVE PATCHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BARRIER METHODS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BARRIER METHODS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BARRIER METHODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MALE CONDOMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MALE CONDOMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MALE CONDOMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL FEMALE CONDOMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL FEMALE CONDOMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL FEMALE CONDOMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DIAPHRAGMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DIAPHRAGMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DIAPHRAGMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CERVICAL CAPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CERVICAL CAPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CERVICAL CAPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PERMANENT METHODS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PERMANENT METHODS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PERMANENT METHODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL TUBAL LIGATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL TUBAL LIGATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL TUBAL LIGATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL VASECTOMY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL VASECTOMY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL VASECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PREVENT IMPLANTATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PREVENT IMPLANTATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PREVENT IMPLANTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SPERMICIDAL ACTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SPERMICIDAL ACTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SPERMICIDAL ACTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SUPPRESS OVULATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SUPPRESS OVULATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SUPPRESS OVULATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL LATEX-BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL LATEX-BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL LATEX-BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL NON-LATEX MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL NON-LATEX MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL NON-LATEX MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL NITRILE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL NITRILE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL NITRILE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL POLYISOPRENE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL POLYISOPRENE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL POLYISOPRENE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL POLYURETHANE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL POLYURETHANE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL POLYURETHANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL LONG-TERM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL LONG-TERM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL LONG-TERM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL SHORT-TERM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL SHORT-TERM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL SHORT-TERM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ON-DEMAND MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ON-DEMAND MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ON-DEMAND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL REGULAR USE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL REGULAR USE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL REGULAR USE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL HOSPITAL PHARMACY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL HOSPITAL PHARMACY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL HOSPITAL PHARMACY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL PHARMACY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL PHARMACY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL PHARMACY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL E-COMMERCE PLATFORMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL E-COMMERCE PLATFORMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL E-COMMERCE PLATFORMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL ONLINE PHARMACY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL ONLINE PHARMACY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL ONLINE PHARMACY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL GENERAL USE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL GENERAL USE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL GENERAL USE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL POST-COITAL USE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL POST-COITAL USE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL POST-COITAL USE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL FEMALE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL FEMALE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL FEMALE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL ADOLESCENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL ADOLESCENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL ADOLESCENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL POST-MENOPAUSAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL POST-MENOPAUSAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL POST-MENOPAUSAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL MALE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL MALE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL MALE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL CONTRACEPTIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUGS, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES (IUDS), 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY BARRIER METHODS, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY PERMANENT METHODS, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUGS, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES (IUDS), 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA CONTRACEPTIVE MARKET SIZE, BY BARRIER METHODS, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA CONTRACEPTIVE MARKET SIZE, BY PERMANENT METHODS, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 178. NORTH AMERICA CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUGS, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES (IUDS), 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA CONTRACEPTIVE MARKET SIZE, BY BARRIER METHODS, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA CONTRACEPTIVE MARKET SIZE, BY PERMANENT METHODS, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 194. LATIN AMERICA CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 196. LATIN AMERICA CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUGS, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES (IUDS), 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE CONTRACEPTIVE MARKET SIZE, BY BARRIER METHODS, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE CONTRACEPTIVE MARKET SIZE, BY PERMANENT METHODS, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUGS, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES (IUDS), 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST CONTRACEPTIVE MARKET SIZE, BY BARRIER METHODS, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST CONTRACEPTIVE MARKET SIZE, BY PERMANENT METHODS, 2018-2032 (USD MILLION)
  • TABLE 222. MIDDLE EAST CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. MIDDLE EAST CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2032 (USD MILLION)
  • TABLE 225. MIDDLE EAST CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2032 (USD MILLION)
  • TABLE 226. MIDDLE EAST CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 228. MIDDLE EAST CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 230. MIDDLE EAST CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. MIDDLE EAST CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 232. MIDDLE EAST CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. AFRICA CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUGS, 2018-2032 (USD MILLION)
  • TABLE 236. AFRICA CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 237. AFRICA CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES (IUDS), 2018-2032 (USD MILLION)
  • TABLE 238. AFRICA CONTRACEPTIVE MARKET SIZE, BY BARRIER METHODS, 2018-2032 (USD MILLION)
  • TABLE 239. AFRICA CONTRACEPTIVE MARKET SIZE, BY PERMANENT METHODS, 2018-2032 (USD MILLION)
  • TABLE 240. AFRICA CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 241. AFRICA CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. AFRICA CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2032 (USD MILLION)
  • TABLE 243. AFRICA CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2032 (USD MILLION)
  • TABLE 244. AFRICA CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 245. AFRICA CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 246. AFRICA CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 247. AFRICA CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 248. AFRICA CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 249. AFRICA CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 250. AFRICA CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2032 (USD MILLION)
  • TABLE 251. GLOBAL CONTRACEPTIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUGS, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES (IUDS), 2018-2032 (USD MILLION)
  • TABLE 257. ASEAN CONTRACEPTIVE MARKET SIZE, BY BARRIER METHODS, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN CONTRACEPTIVE MARKET SIZE, BY PERMANENT METHODS, 2018-2032 (USD MILLION)
  • TABLE 259. ASEAN CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 260. ASEAN CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. ASEAN CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2032 (USD MILLION)
  • TABLE 262. ASEAN CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2032 (USD MILLION)
  • TABLE 263. ASEAN CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 264. ASEAN CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 265. ASEAN CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 266. ASEAN CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 267. ASEAN CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 268. ASEAN CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 269. ASEAN CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2032 (USD MILLION)
  • TABLE 270. GCC CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 271. GCC CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. GCC CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUGS, 2018-2032 (USD MILLION)
  • TABLE 273. GCC CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 274. GCC CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES (IUDS), 2018-2032 (USD MILLION)
  • TABLE 275. GCC CONTRACEPTIVE MARKET SIZE, BY BARRIER METHODS, 2018-2032 (USD MILLION)
  • TABLE 276. GCC CONTRACEPTIVE MARKET SIZE, BY PERMANENT METHODS, 2018-2032 (USD MILLION)
  • TABLE 277. GCC CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 278. GCC CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. GCC CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2032 (USD MILLION)
  • TABLE 280. GCC CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2032 (USD MILLION)
  • TABLE 281. GCC CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 282. GCC CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 283. GCC CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 284. GCC CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 285. GCC CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 286. GCC CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 287. GCC CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2032 (USD MILLION)
  • TABLE 288. EUROPEAN UNION CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 289. EUROPEAN UNION CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 290. EUROPEAN UNION CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUGS, 2018-2032 (USD MILLION)
  • TABLE 291. EUROPEAN UNION CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 292. EUROPEAN UNION CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES (IUDS), 2018-2032 (USD MILLION)
  • TABLE 293. EUROPEAN UNION CONTRACEPTIVE MARKET SIZE, BY BARRIER METHODS, 2018-2032 (USD MILLION)
  • TABLE 294. EUROPEAN UNION CONTRACEPTIVE MARKET SIZE, BY PERMANENT METHODS, 2018-2032 (USD MILLION)
  • TABLE 295. EUROPEAN UNION CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 296. EUROPEAN UNION CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 297. EUROPEAN UNION CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2032 (USD MILLION)
  • TABLE 298. EUROPEAN UNION CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2032 (USD MILLION)
  • TABLE 299. EUROPEAN UNION CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 300. EUROPEAN UNION CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 301. EUROPEAN UNION CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 302. EUROPEAN UNION CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 303. EUROPEAN UNION CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 304. EUROPEAN UNION CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 305. EUROPEAN UNION CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2032 (USD MILLION)
  • TABLE 306. BRICS CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 307. BRICS CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 308. BRICS CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUGS, 2018-2032 (USD MILLION)
  • TABLE 309. BRICS CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 310. BRICS CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES (IUDS), 2018-2032 (USD MILLION)
  • TABLE 311. BRICS CONTRACEPTIVE MARKET SIZE, BY BARRIER METHODS, 2018-2032 (USD MILLION)
  • TABLE 312. BRICS CONTRACEPTIVE MARKET SIZE, BY PERMANENT METHODS, 2018-2032 (USD MILLION)
  • TABLE 313. BRICS CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 314. BRICS CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 315. BRICS CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2032 (USD MILLION)
  • TABLE 316. BRICS CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2032 (USD MILLION)
  • TABLE 317. BRICS CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 318. BRICS CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 319. BRICS CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 320. BRICS CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 321. BRICS CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 322. BRICS CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 323. BRICS CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2032 (USD MILLION)
  • TABLE 324. G7 CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 325. G7 CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 326. G7 CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUGS, 2018-2032 (USD MILLION)
  • TABLE 327. G7 CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 328. G7 CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES (IUDS), 2018-2032 (USD MILLION)
  • TABLE 329. G7 CONTRACEPTIVE MARKET SIZE, BY BARRIER METHODS, 2018-2032 (USD MILLION)
  • TABLE 330. G7 CONTRACEPTIVE MARKET SIZE, BY PERMANENT METHODS, 2018-2032 (USD MILLION)
  • TABLE 331. G7 CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 332. G7 CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 333. G7 CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2032 (USD MILLION)
  • TABLE 334. G7 CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2032 (USD MILLION)
  • TABLE 335. G7 CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 336. G7 CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 337. G7 CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 338. G7 CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 339. G7 CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 340. G7 CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 341. G7 CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2032 (USD MILLION)
  • TABLE 342. NATO CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 343. NATO CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 344. NATO CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUGS, 2018-2032 (USD MILLION)
  • TABLE 345. NATO CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 346. NATO CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES (IUDS), 2018-2032 (USD MILLION)
  • TABLE 347. NATO CONTRACEPTIVE MARKET SIZE, BY BARRIER METHODS, 2018-2032 (USD MILLION)
  • TABLE 348. NATO CONTRACEPTIVE MARKET SIZE, BY PERMANENT METHODS, 2018-2032 (USD MILLION)
  • TABLE 349. NATO CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 350. NATO CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 351. NATO CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2032 (USD MILLION)
  • TABLE 352. NATO CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2032 (USD MILLION)
  • TABLE 353. NATO CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 354. NATO CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 355. NATO CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 356. NATO CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 357. NATO CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 358. NATO CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 359. NATO CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2032 (USD MILLION)
  • TABLE 360. GLOBAL CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 361. UNITED STATES CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 362. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 363. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUGS, 2018-2032 (USD MILLION)
  • TABLE 364. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 365. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES (IUDS), 2018-2032 (USD MILLION)
  • TABLE 366. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY BARRIER METHODS, 2018-2032 (USD MILLION)
  • TABLE 367. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY PERMANENT METHODS, 2018-2032 (USD MILLION)
  • TABLE 368. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 369. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 370. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2032 (USD MILLION)
  • TABLE 371. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2032 (USD MILLION)
  • TABLE 372. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 373. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 374. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 375. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 376. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 377. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 378. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2032 (USD MILLION)
  • TABLE 379. CANADA CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 380. CANADA CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 381. CANADA CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUGS, 2018-2032 (USD MILLION)
  • TABLE 382. CANADA CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 383. CANADA CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES (IUDS), 2018-2032 (USD MILLION)
  • TABLE 384. CANADA CONTRACEPTIVE MARKET SIZE, BY BARRIER METHODS, 2018-2032 (USD MILLION)
  • TABLE 385. CANADA CONTRAC